Skip to main content
. 2017 Dec 27;2(1):1–9. doi: 10.1182/bloodadvances.2017013334

Table 2.

Comparison of patient characteristics based on presence of subclones

Subclone
No Yes All
Variable Level n % n % n % P
ISS I 44 44.0 87 38.0 131 39.8 .60
II 33 33.0 82 35.8 115 35.0
III 23 23.0 60 26.2 83 25.2
Elevated LDH No 91 86.7 184 78.6 275 81.1 .10
Yes 14 13.3 50 21.4 64 18.9
Elevated creatinine No 97 89.8 221 89.8 318 89.8 1.00
Yes 11 10.2 25 10.2 36 10.2
Anemia No 95 88.0 227 92.3 322 91.0 .23
Yes 13 12.0 19 7.7 32 9.0
Hypercalcemia No 100 92.6 229 93.1 329 92.9 .83
Yes 8 7.4 17 6.9 25 7.1
Age, y >60 84 77.8 175 71.1 259 73.2 .24
18-60 24 22.2 71 28.9 95 26.8
Osteolyses None 22 21.8 61 25.6 83 24.5 .39
1 10 9.9 14 5.9 24 7.1
2 6 5.9 9 3.8 15 4.4
>2 63 62.4 154 64.7 217 64.0
≥VGPR after induction No 78 72.2 197 80.1 275 77.7 .13
Yes 30 27.8 49 19.9 79 22.3
≥VGPR after ASCT No 57 52.8 145 58.9 202 57.1 .30
Yes 51 47.2 101 41.1 152 42.9